The report, the first that MediPurpose has publicly published, showed a complaint rate of less than one in five million for fiscal year 2012.
The report also illustrated a downward trend in annual complaint rates since FY 2003.
"We are very proud of our SurgiLance safety lancet's quality record," said MediPurpose founder and CEO Patrick Yi. "Of course, the goal always is to not have any complaints, which is a significant challenge considering the millions of lancets that we sell each year.
"Still, we will continue to strive to manufacture a superior safety lancet (http://www.medipurpose.com/
Yi added that the company will publish more statistics in future quality reports.
About SurgiLance Safety Lancets
MediPurpose introduced the SurgiLance safety lancet in 1999. Since then, it has sold approximately one billion safety lancets worldwide.
Valued for its safety, comfort, and ease of use, the SurgiLance safety lancet is one of the top-selling fingerstick devices in the United States and is available to healthcare professionals worldwide through a broad network of distributors.
The SurgiLance portfolio currently features seven unique models, ranging from 18-28 gauges and 1.0-2.3 mm penetration depths.
Along with SurgiLance, MediPurpose's Lancing Devices product portfolio also includes the babyLance(tm)
For more information about SurgiLance safety lancets -- including no-cost product sample requests -- please visit http://www.medipurpose.com/
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance(tm)
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com.